Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 1:35 AM
Study NCT ID:
NCT07379957
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-02
First Post:
2025-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.
Sponsor:
University Hospital, Bordeaux
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-26
First Submit QC Date:
None
Study First Post Date:
2026-02-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-23
Last Update Post Date:
2026-02-02
Last Update Post Date Type:
ACTUAL